The New Cardiac Electrophysiology Technology Program (CEPT) for Allied Health Professionals
- Volume 11 - Issue 1 - January, 2011
- Posted on: 1/4/11
- 0 Comments
- 5843 reads
Future of the CEPT
Over the last year, healthcare has continued to headline the national political landscape. This fall, Joe Giron had the privilege of participating in a healthcare roundtable, moderated by a political action committee. The main point made was that the future of national healthcare reform will be murky for some time, though it is very clear that access and efficiency will be the actualized endpoints. With that in mind, we have a long-term plan for these CEPT programs.
Graduates of the CEPT program will be qualified to sit for boards and for employment with not just acute care hospital CCL/EP labs, but also with hospital or physician rhythm management clinics, clinical support, and sales positions with various bio-technology companies. The development of this program was in large part directed from internal research that demonstrated that the future needs of hospitals, physicians, bio-tech companies and healthcare reform was to meet the emerging challenges of science and therapy required for the maturation of electrophysiology.
Vision and Goals
There exists a substantial and real opportunity for professional growth within the EP health science community, for those wishing to pursue or advance their career. The hard work and efforts of the core administrative team of Loma Linda University’s School of Allied Health has resulted in the actualization of the Cardiac Electrophysiology Technology Program starting in January 2011.
Our goal is to increase the awareness and access for the EP community and patients at large. This CEPT program adds to both elements, as the education contributes to the awareness, and the new skill set of the graduates will instrumentally factor in to increasing patient access to EP across the healthcare system.
1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-2375.
2. Gersh, B. The changing epidemiology of non-valvular atrial fibrillation: The role of novel risk factors. Eur Heart J Supp. 2005;7(Suppl C):C5-C11.